American Society of Clinical Oncology (ASCO)

Three medical students— Nkeiruka Nwobu, MPH, BS (Rutgers New Jersey Medical School), Cheryssa Hislop, BS (University of Pennsylvania Perelman School of Medicine), and Alejandra Curbelo-Paz, BS (University of Pittsburgh School of Medicine)—shared their experiences balancing academics, community, and self-care during their first year of medical school. All three are past participants of our Oncology Summer Internship program, which introduces medical students from populations underrepresented in medicine to the field of oncology. Read their stories: https://lnkd.in/ehJKTrqP

Did you hear the news? We are excited to announce that for #ASCO25 we’re offering payment waivers to first authors from low-income and lower-middle-income countries as defined by the World Bank, boosting our longtime support of making research contributions more accessible and amplifying diverse voices in oncology! Don’t miss this opportunity to share your high-impact research on the largest global oncology stage. Authors must apply for the waiver at the time of submission. 🔗 View submission resources: https://brnw.ch/21wOQHl

Check out our newly issued rapid recommendation guideline update on Systemic Therapy for Small Cell Lung Cancer. Read more: https://brnw.ch/21wOPiC For more on this guideline update, read an in-depth analysis from #ASCODailyNews featuring insights from Expert Panel co-chair Dr. Gregory P. Kalemkerian: https://brnw.ch/21wOPiB

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Nominating Committee – Undesignated Member seat: • Petros Grivas, MD, PhD • Erika P. Hamilton, MD • Rana R. McKay, MD, FASCO • Flavio G. Rocha, MD There are two seats available, and each seat has a three-year term. Learn more about each candidate, determine your voting eligibility, and make your voice heard at https://brnw.ch/21wOKr2

Time is running out—auditions for ASCO Voices 2025 close TONIGHT! This is your chance to take the stage at the ASCO Annual Meeting and share YOUR story with the global oncology community. Whether it’s a powerful lesson learned, a call to action, or a moment where collaboration made all the difference in your clinic, your voice could inspire fellow oncology professionals and drive meaningful change. Don’t let this opportunity pass by—submit your audio audition today: https://brnw.ch/21wOGd2

Join us in South Florida for our 3 in-person Quality Training Program sessions, hosted by Memorial Cancer Institute! This interactive 6-month program takes practices through a site-specific quality improvement project with guidance from our coaches. Apply by December 2! https://brnw.ch/21wODzu

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Nominating Committee – Designated Community Oncologist seat: • Suzanne Cole, MD, FACP, FASCO • Jasmine Kamboj, MD, FASCO This seat has a three-year term, and there is one seat available. Learn more about each candidate, determine your voting eligibility, and make your voice heard at https://brnw.ch/21wODiw

A common definition of #healthequity is that it means everyone has a fair opportunity to attain their highest level of health. For three students who participated in our Oncology Summer Internship Program, the meaning is personal—driving them to pursue careers in medicine. Medical students Ellen W. Essien, Salvador Aguirre, and Fabiola Geralna Pierre shared their experiences with us. #ASCOHealthEquity Read their stories: https://brnw.ch/21wOBP5

A new study at a large U.S. health system has found that routine comprehensive genomic profiling, or CGP, at the time of diagnosis can greatly increase the use of precision therapies among patients with advanced cancer and improve their overall survival. Among more than 3,200 patients with advanced cancer whose biopsies were tested using an in-house CGP assay, two-thirds had “actionable” biomarkers, meaning they were candidates for guideline-recommended targeted therapy or immunotherapy or for clinical trials testing precision therapies. “That was pretty striking,” said co-author Dr. Brian Piening, of the Earle A. Chiles Research Institute at the Providence Cancer Institute. “The majority of patients could potentially be treated with a therapy that was not just chemo.” ASCO Daily News has more on this new study, recently published as part of a special series in JCO Oncology Practice: https://brnw.ch/21wOBmf #JCOOP

Check out our new living guideline update, Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations. Learn more: https://brnw.ch/21wOA3r